Evidence map›Paper›PMID 41882272›Full record

ArticleScientific reports2026

Fortification of Daqu with the soy sauce-functional fungus Aspergillus oryzae CICC 2339: investigations into Daqu properties and Baijiu brewing outcomes.

Yougui Yu, Tao Yang, Dongcai Zhu, Jie Li, Lipin Wu, Xinshe Li, Xiuqiong Huang, Zhengpei Chen, Xiangyang Tang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yougui Yu *Modern Industrial College of Brewing Ecotypically in Hunan Province, Shaoyang University, Shaoyang, 422000, Hunan, China. youguiyu_syu@163.com.
Tao Yang *Jiangxi Lidu Liquor Co., Ltd, Nanchang, 331700, Jiangxi, China. taoyang298@163.com.
Dongcai ZhuJiangxi Lidu Liquor Co., Ltd, Nanchang, 331700, Jiangxi, China.
Jie LiJiangxi Lidu Liquor Co., Ltd, Nanchang, 331700, Jiangxi, China.
Lipin WuJiangxi Lidu Liquor Co., Ltd, Nanchang, 331700, Jiangxi, China.
Xinshe LiKey Laboratory of Brewing Ecotypically Technology and Application of Hunan University, Shaoyang University, Shaoyang, 422000, Hunan, China.
Xiuqiong HuangModern Industrial College of Brewing Ecotypically in Hunan Province, Shaoyang University, Shaoyang, 422000, Hunan, China.
Zhengpei ChenChongqing Zhengya Biotechnology Co., Ltd. , 405807, Chongqing, China. zhengyabio@126.com.
Xiangyang TangJiangxi Lidu Liquor Co., Ltd, Nanchang, 331700, Jiangxi, China. txy799@zjld.com.

Funding

Central Government-Guided Local Development Funding Program 2024ZYC029
6 · The paper itself

Abstract

The comprehensive effects of cross-industry Bioaugmentation with Aspergillus oryzae CICC 2339, derived from bean-based fermented foods, on traditional medium-high temperature Daqu and its fermented crude Baijiu were evaluated, with the aim of providing a scientific basis for optimizing the quality of Texiangxin Baijiu. Application of Aspergillus oryzae CICC 2339 in Daqu fortification effectively regulated the growth of thermotolerant dominant bacteria and significantly increased the contents of flavor compounds (particularly those with sauce and floral aromas) in fortified Daqu and its fermented crude Baijiu. This study provides an innovative approach for producing high-quality Texiangxin Baijiu using medium-high temperature Daqu, and the findings hold both scientific and practical value for advancing Baijiu quality..

Indexed as

Aspergillus oryzaeFood, FortifiedSoy FoodsFermentationFood MicrobiologyAroma enhancement performanceAspergillus oryzaeCross-industry applicationFortified DaquMicrobial-enzyme system

Identifiers

PMID41882272
PMCPMC13168219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.